Navigation Links
Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
Date:5/8/2012

BETHESDA, Md., May 8, 2012 /PRNewswire-iReach/ -- Reimbursement strategy has become an integral component of drug and device development and commercialization plan. For new product launches it is becoming critical to demonstrate clinical, safety, economic and quality of life benefits versus comparators to payers, providers and patients. Novel Health Strategies, LLC's presentations at ISPOR 2012 highlight these trends: 

IMPACT OF 2009-2011 GLOBAL HEALTH CARE REFORMS ON PRICING, ACCESS AND HEALTH OUTCOMES STRATEGY (UT2, Tuesday, June 5, 2012, Podium Presentation)

COST EFFECTIVENESS TRENDS OF HIGH BUDGET IMPACT DRUGS (2006-2012) (CE1, Monday, June 4, 2012, Podium Presentation)

DEVELOPING BUDGET IMPACT MODEL FOR RARE DISEASES: CASE IN POINT CUTANEOUS T-CELL LYMPHOMA (PCN30, Wednesday, June 6, 2012)

ELECTRONIC PATIENT REPORTED OUTCOMES AND DATA TOOL FOR CHRONIC DISEASE MANAGEMENT (PROCDIM): CASE IN POINT PROSTATE CANCER (PIH32, Tuesday, June 5, 2012)

ONCOLOGY DRUG PRICES IN THE UNITED STATES AND THE UNITED KINGDOM: IMPLICATIONS FOR PRICING STRATEGY AND DRUG ACCESS (PCN116, Wednesday, June 6, 2012)

SYSTEMATIC REVIEW OF CLINICAL EFFICACY AND SAFETY OUTCOMES OF ANTI-VEGF THERAPIES FOR METASTATIC COLORECTAL CANCER (PCN114, Wednesday, June 6, 2012)

SYSTEMATIC REVIEW OF INTERFERON FREE BASED REGIMENS FOR CHRONIC HEPATITIS C TREATMENT (PIN5, Wednesday, June 6, 2012)

TRENDS IN RATE AND COST OF HOSPITALIZATIONS DUE TO CHRONIC KIDNEY DISEASE (CKD) IN THE UNITED STATES (PUK13, Tuesday, June 5, 2012)

Relevant References:

*Targeted Cancer Therapies, Nature Reviews Drug Discovery 9, 427-428 (June 2010)
http://novelhealthstrategies.com/Targeted_Cancer_Therapies.pdf
*What's Fueling the Biotech Engine-2010 to 2011, Nature Biotechnology 29, 1083–1089 (2011)
http://www.nature.com/nbt/journal/v29/n12/abs/nbt.2060.html
*Impact of 2009-2011 Global Healthcare Reforms on Access, Pricing and Health Outcomes Strategy, June 2, 2012
http://www.ispor.org/meetings/washingtondc0512/Program_060512.asp#podiums3

About Novel Health Strategies
Novel Health Strategies, LLC (http://www.novelhealthstrategies.com) is an award winning team of experienced professionals with expertise in healthcare strategy, research, policy, publications, health economics and outcomes research, modeling, and pricing and market access strategy. Novel Health team has led strategy projects for majority of top 50 pharmaceutical, biotech and device companies. Novel Health has large network of internal and external stakeholders and has published several thought leading strategy perspectives, including the 'What's fueling the biotech engine' annual series in Nature Biotech, cited and quoted by more than two hundred peer-reviewed publications and agencies (FDA, EMA and others). Novel Health has presented industry trends and perspectives at ISPOR, AMCP and BIO meetings. To learn more about Novel Health team's experience, case studies and capabilities, contact at the address on this press release.

Media Contact: Saurabh Aggarwal, PhD Novel Health Strategies, LLC, (202) 618-9365, info@novelhealthstrategies.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Novel Health Strategies, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
3. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
4. IDM Pharma Announces Upcoming Clinical Data Presentations
5. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
6. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
7. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
8. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
9. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
10. Genmab Announces Upcoming Ofatumumab Studies
11. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2017)... , May 11, 2017  Thornhill Research ... has been awarded an $8,049,024 USD five-year, firm-fixed-priced, ... through the Canadian Commercial Corporation (CCC) ( ... Anesthesia Systems to administer general anesthesia to patients ... "The US Marine Corps have been ...
(Date:5/10/2017)... May 10, 2017  The Corporate Whistleblower Center ... of sleep therapy clinics to call us anytime ... clinic is involved in a substantial scheme to ... hearing from an employee of a medical equipment ... scheme to provide medical practice groups with extra ...
(Date:5/9/2017)... 9, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... today announced it has earned a spot on ... The Company was ranked among 500 U.S. employers as ... Healthcare Equipment and Services. The annual ... anonymous, independent survey of over 30,000 employees across 25 ...
Breaking Medicine Technology:
(Date:5/19/2017)... ... 18, 2017 , ... ML Billing, 2016 Billing Company of the Year ... in large group practices, is pleased to announce their 30th anniversary. Not only has ... standard in all aspects of full-service medical billing. This has allowed ML Billing to ...
(Date:5/19/2017)... ... May 18, 2017 , ... ... who served eight American presidents of both political parties, will become the 9th ... General Colin L. Powell, USA (Retired) as Chairman in May, 2018. , Secretary ...
(Date:5/18/2017)... MD (PRWEB) , ... May 18, 2017 , ... Dr. ... disease treatment and educating her community on the link between this condition and serious ... have moderate to severe periodontal disease in Annapolis, MD, and seeking treatment ...
(Date:5/18/2017)... ... May 18, 2017 , ... Summit BHC (Summit), ... acquisition of English Mountain Recovery. Located in Sevierville, Tennessee approximately 30 miles ... in the state and brings the Company’s total number of operating facilities to ...
(Date:5/18/2017)... Boulder, CO (PRWEB) , ... May 18, 2017 , ... ... spotlight on low-performing schools. A remedy offered to “turn around” low-performance in school districts ... elsewhere. , School Closure as a Strategy to Remedy Low Performance , authored ...
Breaking Medicine News(10 mins):